Skip to content

mHealth Effect on Multiple Sclerosis Patients' Quality of Life and Self-care Practices

Arabic Mobile Application for Multiple Sclerosis (MS) Patients and Its Effect on Their Quality of Life and Self-care Practices

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06769763
Enrollment
74
Registered
2025-01-10
Start date
2025-01-14
Completion date
2025-09-15
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple sclerosis, Quality of life, Self-care, mHealth, Arabic Application

Brief summary

The goal of this clinical trial is to learn if an Arabic mobile application for multiple sclerosis patients will improve self-care practice and the quality of life of patients or not. The main question it aims to answer is: Does the Arabic mobile application for MS patients will improve their self-care and quality of life? Participants will: Use the developed application or usual care without using the application for 3 months Be followed up during the 12 week period and asked to follow the instructions in the application

Detailed description

This study aims to build and test a culturally appropriate mobile application in Arabic for MS (multiple sclerosis) patients in Egypt. It will focus on self-care practices and quality of life enhancement via educational material provision, symptom tracking as well as medication adherence reminders among other possible functions depending on user preferences. The study shall evaluate how effective the developed app is in promoting self-care practices and improving the quality of life for MS patients compared to a control group who do not use the app.

Interventions

OTHERMy Journey with MS application

This is an Arabic application for MS patients that provides them with information about self-care like nutrition, exercise, mental health, and self-management, in addition to other features like symptom tracking and medication reminders.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed clinically with multiple sclerosis. * From 18 to 50 years old (adult). * With smartphones. * Willing to participate in the study and use the mobile application.

Exclusion criteria

* Patients who are bedridden or in a wheelchair * Illiterate patients.

Design outcomes

Primary

MeasureTime frameDescription
The effect of mHealth on the self-care practices of multiple sclerosis patientsFrom enrollment to the end of follow-up at 12 weeksThe effect of mHealth on the self-care practices of multiple sclerosis patients will be assessed using the self-care for chronic disease inventory questionnaire. The score ranges from 0 to 100, the higher the score the better the self-care practices.
The effect of mHealth on the quality of life of multiple sclerosis patientsFrom enrollment to the end of follow-up at 12 weeksThe effect of mHealth on the quality of life (QoL) of multiple sclerosis patients will be assessed using the multiple sclerosis international quality of life (Musiqol) questionnaire. The score will be transformed into a range from 0 to 100; the higher the score, the better the QoL practices.

Secondary

MeasureTime frameDescription
The usability of the developed applicationAfter 12 weeks of enrollmentThe usability of the developed application will be assessed using the app usability questionnaire. The patients will choose a number between 1 to 7 (Likert scale), as 1 strongly disagree, 2 disagree, 3 somewhat disagree 4 neutral, 5 somewhat agree, 6 agree, and 7 strongly agree. Then the total average of all scored items for each participant will be calculated; the higher the average, the better the app's usability

Countries

Egypt

Contacts

STUDY_CHAIRNargis Albert Labib

Professor of public Health and Community Medicine, Faculty of Medicine, Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026